HIBT Lab! Immunai: Noam Solomon

HIBT Lab! Immunai: Noam Solomon

According to the CDC, 6 in 10 adults in the U.S. have a chronic disease like cancer or diabetes. Meanwhile, the process for discovering new drug treatments is critically expensive and inefficient. About 90% of drug candidates fail to gain FDA approval; the average cost to develop a new drug is over $1 billion; and testing can take over 10 years.


Noam Solomon is on a mission to change this. His company, Immunai, is using artificial intelligence to create an atlas of the human immune system.


This week on How I Built This Lab, Guy talks with Noam about how Immunai’s immune system mapping is accelerating the development of new personalized drug therapies. Plus, Noam shares how Immunai’s culture of ‘not knowing’ drives scientific innovation.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episoder(805)

Guayakí Yerba Mate: David Karr and Chris Mann

Guayakí Yerba Mate: David Karr and Chris Mann

In the mid-1990’s most Americans had probably never even heard of yerba mate, but when David Karr and Chris Mann were first introduced to the South American drink, they were hooked. Together with thre...

28 Nov 20221h 11min

HIBT Lab! Goodr: Jasmine Crowe-Houston

HIBT Lab! Goodr: Jasmine Crowe-Houston

Millions of Americans don’t have enough to eat — a startling fact considering 40% of the food produced in the U.S. gets thrown away. And a lot of that food… from restaurants, supermarkets, office buil...

24 Nov 202245min

Roku: Anthony Wood

Roku: Anthony Wood

Anthony Wood helped transform the media landscape…twice. First, in the early 2000’s, when he invented a device that let you record, pause, and re-watch live TV. The DVR was a game-changer, but the com...

21 Nov 20221h 12min

HIBT Lab! Tala: Shivani Siroya

HIBT Lab! Tala: Shivani Siroya

‘This is not our customer...’ That was the common justification banks used to deny loans to the entrepreneurs Shivani Siroya supported through her work with the United Nations. While it’s not unusual ...

17 Nov 202234min

Chobani: Hamdi Ulukaya

Chobani: Hamdi Ulukaya

As a newly arrived immigrant from Turkey, Hamdi Ulukaya learned to be resourceful, determined, and even stubborn when he needed to be. All those traits would serve him well as he began to navigate the...

14 Nov 20221h 30min

HIBT Lab! Tomorrow.io: Shimon Elkabetz

HIBT Lab! Tomorrow.io: Shimon Elkabetz

Our planet is warming, and many parts of the world are not equipped to accurately predict the heat waves, hurricanes, tornadoes, wildfires and floods that are becoming more frequent and intense due to...

10 Nov 202240min

Ooni Pizza Ovens: Darina Garland and Kristian Tapaninaho

Ooni Pizza Ovens: Darina Garland and Kristian Tapaninaho

When you think of pizza, the first place that comes to mind probably isn’t Finland…or Scotland. But that’s where the two founders of the outdoor pizza oven brand Ooni grew up. In 2012, Kristian Tapani...

7 Nov 20221h 9min

HIBT Lab! MKBHD: Marques Brownlee

HIBT Lab! MKBHD: Marques Brownlee

“Right now I have approximately 70-ish subscribers,” declared a teenage Marques Brownlee at the beginning of his 100th YouTube video back in 2009. Marques recorded his first of many product reviews ea...

3 Nov 202249min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
rss-penger-polser-og-politikk
e24-podden
rss-borsmorgen-okonominyhetene
pengepodden-2
pengesnakk
utbytte
livet-pa-veien-med-jan-erik-larssen
finansredaksjonen
morgenkaffen-med-finansavisen
tid-er-penger-en-podcast-med-peter-warren
okonomiamatorene
lederpodden
rss-markedspuls-2
rss-sunn-okonomi
lydartikler-fra-aftenposten
rss-fa-makro
shifter
boligbobla